Back to the main directory
Company Analysis / Equity
- Ironwood - A Brighter Year Ahead in 2026 (BUY, TP $15 [17], 10pgs) by New Street Research
- Income jumps in H2, well ahead of forecasts by Equity Development
- UCB - Highest Conviction Long (BUY, TP EUR300, 13pgs) by New Street Research
- DNG: Increasing Target Price on 2026 Guidance by Atrium Research Corporation
- Avacta: pre|CISION prospects build by Trinity Delta
- EDG: New Geochem Anomaly Extends Royal Shear Trend by Atrium Research Corporation
- MTT: Options New Brunswick Epithermal Gold Project by Atrium Research Corporation
- ROMJ: Lots of Positive Developments; Reiterating Bullish Stance by Atrium Research Corporation
- ROMJ: Premium Cannabis Leader Poised for Accelerated Growth by Atrium Research Corporation
- SPA: Intersects 1.35 g/t Au over 133m; Assays Pending by Atrium Research Corporation
- Roche - 2026 Risks Mounting – D/G to HOLD (TP CHF350 [370], 11pgs) by New Street Research
- DRX: Increasing Target Price on $140M in New Contracts by Atrium Research Corporation
- CAPT: 1,130 g/t AgEq Over 1.5m at Cruz De Plata by Atrium Research Corporation
- NKG: SPE Footprint Expanded to 300m by 500m by Atrium Research Corporation
- LVG: Completes Area C Drilling; Confirms Pit Expansion Potential by Atrium Research Corporation
- MSA: 2026 Guidance Outlines Growth Initiatives by Atrium Research Corporation
- CAPT: Intersects 1,833 g/t AgEq over 1.5m; Core Rig On-Site by Atrium Research Corporation
- GSK - Cut to Sell - Recent Surge Unjustified (SELL [HOLD], TP £19 [18], 17pgs) by New Street Research
- CTEK: Entering New Growth Phase with International Momentum by Atrium Research Corporation
- BQE: Signs New Contract; Increasing Target Price by Atrium Research Corporation
- Sandoz - A Structural Long (BUY, TP CHF75 [46], 14pgs) by New Street Research
- ROMJ: First Harvest at Cascadia; On Time and On Budget by Atrium Research Corporation
- MTT: Humber Stream Results Support Copper-Cobalt Thesis by Atrium Research Corporation
- Novo - Still A Sell – PT Cut to DKK200 (SELL, TP DKK200 [230], 12pgs) by New Street Research
- ARG: Increasing Target Price on Strong Execution by Atrium Research Corporation